Baixar PDF
Artigo anterior
Voltar à página
Artigo seguinte
If you have problems to see the content please click here
Outros usuários também visualizaram estes artigos
PRELIMINARY RESULTS FROM A MULTICENTER PHASE 2/3 STUDY OF NEXT-GENERATION SICKLE HEMOGLOBIN POLYMERIZATION INHIBITOR OSIVELOTOR (GBT021601) FOR THE TREATMENT OF PATIENTS WITH SICKLE CELL DISEASE
SL Saraf; SU Abdullahi; AM Akinsete; FA Fasola; M Idowu; S Pennington; WB Ershler; MP Stagg; EA Lisbon; F Montealegre-Golcher;
Hematol Transfus Cell Ther. 2024;46 Supl 4:S30
PADRÕES DE USO DE VOXELOTOR EM UM ESTUDO MULTICÊNTRICO DO MUNDO REAL DE PACIENTES COM DOENÇA FALCIFORME
B Andemariam; M Idowu; N Shah; R Drachtman; A Glaros; M Achebe; A Nero; F Montealegr-Golcher; S Curtis; C Minniti;
Hematol Transfus Cell Ther. 2023;45 Supl 4:S36-7
TRIALS IN PROGRESS: THE THRIVE STUDIES EVALUATING THE EFFICACY, SAFETY, AND LONG-TERM TREATMENT WITH INCLACUMAB, A P-SELECTIN INHIBITOR, IN PATIENTS WITH SICKLE CELL DISEASE
B Andemariam; A Inati; R Colombatti; C Minniti; C Brown; M Hottmann; S Gray; C Hoppe; F Montealegre-Golcher; P Yue;
Hematol Transfus Cell Ther. 2022;44 Supl 2:S27-8